These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 567757)

  • 1. Evidence for a possible dopaminergic link in the action of acetylcholine in the rat substantia nigra.
    James TA; Massey S
    Neuropharmacology; 1978 Sep; 17(9):687-90. PubMed ID: 567757
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis.
    Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Rosales MG; Aceves J
    Neuroscience; 1994 Sep; 62(2):441-7. PubMed ID: 7830890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat.
    Agid Y; Guyenet P; Glowinski J; Beaujouan JC; Javoy F
    Brain Res; 1975 Mar; 86(3):488-92. PubMed ID: 1116013
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stereotyped movements and substantia nigra-corpus striatum dopaminergic function in the rat: action of methylphenidate after inhibition of monoamine oxidase].
    Duteil J; de Sereville JE; Multon MF; Pessonnier J; Rambert FA
    Ann Pharm Fr; 1987; 45(1):25-34. PubMed ID: 3662339
    [No Abstract]   [Full Text] [Related]  

  • 5. Amantadine actions on acetylcholine and GABA in striatum and substantia nigra of rat in relation to behavioral changes.
    Bak IJ; Hassler R; Kim JS; Kataoka K
    J Neural Transm; 1972; 33(1):45-61. PubMed ID: 4674484
    [No Abstract]   [Full Text] [Related]  

  • 6. Rotational behaviour and striatal dopamine metabolism following unilateral activation of nigral GABA mechanisms: GABA-like modulation of dopaminergic and non-dopaminergic neurons in rat substantia nigra [proceedings].
    Waddington JL
    Br J Pharmacol; 1978 Jun; 63(2):384P. PubMed ID: 566600
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
    Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
    Neuropharmacology; 1977; 16(7-8):511-8. PubMed ID: 199852
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
    Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in dopaminergic and cholinergic activity and function in the nigro-striatal system of the rat.
    Miller JC
    Psychoneuroendocrinology; 1983; 8(2):225-36. PubMed ID: 6353470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ethanol on turnover and function of striatal dopamine.
    Lai H; Makous WL; Horita A; Leung H
    Psychopharmacology (Berl); 1979 Mar; 61(1):1-9. PubMed ID: 108711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of posterior pituitary neuropeptides on the nigrostriatal dopaminergic system.
    Schulz H; Kovács GL; Telegdy G
    Eur J Pharmacol; 1979 Aug; 57(2-3):185-90. PubMed ID: 573691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotyped behaviour after cholinergic, but not dopaminergic, stimulation of the substantia nigra in rats.
    Decsi L; Nagy J; Zámbó K
    Life Sci; 1978 Jun; 22(21):1873-8. PubMed ID: 566832
    [No Abstract]   [Full Text] [Related]  

  • 14. Nigro-neostriatal dopaminergic activity and axonal protein transport during morphinization and withdrawal in rats.
    Iwamoto ET; Craves RB; Loh HH; Meyerhof J; Way EL
    Proc West Pharmacol Soc; 1975; 18():288-93. PubMed ID: 1237141
    [No Abstract]   [Full Text] [Related]  

  • 15. The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol.
    Snyder SH; Creese I; Burt DR
    Psychopharmacol Commun; 1975; 1(6):663-73. PubMed ID: 1241457
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic suppression of feeding and oral stereotypy following microinjections of carbachol into substantia nigra.
    Taha EB; Redgrave P
    Neurosci Lett; 1980 Dec; 20(3):357-61. PubMed ID: 6255380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenal medulla grafts enhance functional activity of the striatal dopamine system following substantia nigra lesions.
    Becker JB; Freed WJ
    Brain Res; 1988 Oct; 462(2):401-6. PubMed ID: 3142637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrastriatal dopaminergic grafts restore inhibitory control over striatal cholinergic neurons.
    Herman JP; Lupp A; Abrous N; Le Moal M; Hertting G; Jackisch R
    Exp Brain Res; 1988; 73(2):236-48. PubMed ID: 3145893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.